EveryONE Medicines is committed to developing individualized precision medicines targeting genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. Momentum is building as technological advances with genomic testing and the prevalence of testing is improving rapidly to identify the rarest of rare mutations. Through a collaborative effort across all stakeholders in the treatment and diagnosis of rare genetic disease, EveryONE Medicines will bring a scalable solution to meet the needs of the individual patient who currently has limited hope.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 501 Boylston Street, Boston,massachusetts 02116,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.everyonemedicines.com
- Keywords
- Mercer Island.
- HQ
- Boston, Massachusetts
Everyone Medicines Questions
Everyone Medicines's website is http://www.everyonemedicines.com
Everyone Medicines's LinkedIn profile is https://www.linkedin.com/company/everyone-medicines-inc
Everyone Medicines has
12 employees.
View email and phone details for 12
employees at Everyone Medicines.
Everyone Medicines's industry is
Biotechnology Research
Everyone Medicines's top competitors are
N=1 Collaborative,
Pepgen,
Liberate Bio,
Fam177a1 Research Fund,
Mila's Miracle Foundation,
Axia Medicine,
Deep Genomics,
Trace Neuroscience,
Arch Venture Partners,
Gabaa Receptor Alliance.
Everyone Medicines's categories are Biotechnology Research
Everyone Medicines's founding year is 2020
